Moderna Drops 11%, ImmunityBio Slide Wakes Biotech Rout
Biotech shares retreat as Moderna slides 11% and ImmunityBio falls, with Sarepta also sinking amid a broad market rot...
Choosing between SP 500 and multi-asset strategies depends on goals and risk comfort. This intro contrasts outcomes to guide retirement design.
26,268 articlesBiotech shares retreat as Moderna slides 11% and ImmunityBio falls, with Sarepta also sinking amid a broad market rot...
A fresh recall of magsafe battery chargers recalled details new fire hazards linked to lithium-ion cells, with refund...
Oil prices jumped after renewed fighting between the U.S. and Iran, delivering the prices largest two-day percentage ...
A Tuesday rally put Tower Semiconductor in the spotlight as investors priced in capacity upgrades and stronger demand...
A CDC director nominee faced tough questions about political interference and whether she would defy pressure from th...
Rocket Lab shares hover near $67 as July odds tilt toward downside. This story breaks down what prediction markets be...
Bitcoin whales boosted holdings by 200,000 BTC in the last 30 days, yet price momentum cooled as underwater traders c...
Winter demand and a growing data-center footprint push grid strain. The Trump administration accelerates a coal reviv...
The Supreme Court’s bombshell tariff decision blocks emergency levies but leaves unresolved how firms recover roughly...
Analysts warn that the russian economy eating itself is taking hold as sanctions bite and Moscow doubles down on defe...
Hims & Hers Health fell after guiding Q1 2026 revenue below expectations, citing a $65 million headwind from regulato...
NVIDIA is expected to report a $65.7 billion Q4 revenue figure as investors weigh margin recovery against AI-driven d...